UTIs

R&D

Exploring the growing threat of UTIs, the need for new antibiotics, and GSK’s role in advancing targeted treatments.

News

Rapid urine tests could help NHS ensure that antibiotics are used appropriately.

News

Lilly has continued its lengthy streak of acquisitions in 2026 with a $2.88 billion agreement to buy immunology and inflammation specialist Merida.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.